|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.837
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.427
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.398
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.368
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.281
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.265
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.230
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.216
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.209
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.202
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.191
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.185
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.182
|
|
|
|
contact inhibition
|
GO:0060242 |
3 |
0.177
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.166
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.164
|
|
|
|
antibacterial peptide biosynthetic process
|
GO:0002780 |
2 |
0.161
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.159
|
|
|
|
negative regulation of cell proliferation involved in contact inhibition
|
GO:0060244 |
3 |
0.158
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.157
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.149
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.146
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.145
|
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.144
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.140
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.123
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.123
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.118
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.108
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.094
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.092
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.089
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.087
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.084
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.083
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.083
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.081
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.080
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.080
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.079
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.077
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.076
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.075
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.075
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.075
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.075
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.074
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.074
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.073
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.071
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.070
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.070
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.070
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.069
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.069
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.069
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.067
|
|
|
|
antibacterial peptide secretion
|
GO:0002779 |
1 |
0.066
|
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.064
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.064
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.062
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.062
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.062
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.061
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.061
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.061
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.060
|
|
|
|
antimicrobial peptide secretion
|
GO:0002776 |
1 |
0.060
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.058
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.058
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.058
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.057
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.057
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.056
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.056
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.055
|
|
|
|
physiological cardiac muscle hypertrophy
|
GO:0003301 |
3 |
0.055
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.053
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.052
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.052
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.051
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.050
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.048
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.047
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.047
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.046
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.045
|
|
|
|
fibril organization
|
GO:0097435 |
2 |
0.045
|
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.045
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.045
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.045
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.045
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.045
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.045
|
|
|
|
protein heterotrimerization
|
GO:0070208 |
8 |
0.044
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.044
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.044
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.044
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.043
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.043
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.043
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.043
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.042
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.041
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.041
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.041
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.041
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.041
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.041
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.040
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.040
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.040
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.040
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.040
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.039
|
|
|
|
cellular response to nitric oxide
|
GO:0071732 |
4 |
0.038
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.038
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.038
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.038
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.038
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.038
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.038
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.038
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.038
|
|
|
|
endochondral bone growth
|
GO:0003416 |
19 |
0.038
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.037
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.037
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.037
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.036
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.036
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.035
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.035
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.035
|
|
|
|
regulation of cell growth involved in cardiac muscle cell development
|
GO:0061050 |
3 |
0.035
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.035
|
|
|
|
cell killing
|
GO:0001906 |
67 |
0.035
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.034
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.034
|
|
|
|
negative regulation of macrophage chemotaxis
|
GO:0010760 |
1 |
0.034
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.034
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.033
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.033
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.033
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.033
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.032
|
|
|
|
negative regulation of gastrulation
|
GO:2000542 |
3 |
0.032
|
|
|
|
antibacterial humoral response
|
GO:0019731 |
8 |
0.032
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.032
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.032
|
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.031
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.031
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.031
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.030
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.030
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.030
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.030
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.030
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.029
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.029
|
|
|
|
cell aggregation
|
GO:0098743 |
18 |
0.029
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.029
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.029
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.029
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.029
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.028
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.028
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.028
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.028
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.027
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.027
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.027
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.027
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.027
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.027
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.027
|
|
|
|
killing by host of symbiont cells
|
GO:0051873 |
11 |
0.027
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.027
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.027
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.026
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.026
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.026
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.026
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.026
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.025
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.025
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.025
|
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.025
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.025
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.025
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.024
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.024
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.024
|
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.024
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.024
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.024
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.024
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.024
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.024
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.024
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
32 |
0.024
|
|
|
|
disruption of cells of other organism
|
GO:0044364 |
13 |
0.024
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.023
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
19 |
0.023
|
|
|
|
cell growth involved in cardiac muscle cell development
|
GO:0061049 |
3 |
0.023
|
|
|
|
regulation of thymocyte migration
|
GO:2000410 |
2 |
0.023
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.023
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.023
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.023
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.023
|
|
|
|
macrophage chemotaxis
|
GO:0048246 |
14 |
0.023
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.023
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.022
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.022
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.022
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.022
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.022
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.022
|
|
|
|
phagolysosome assembly
|
GO:0001845 |
3 |
0.022
|
|
|
|
regulation of macrophage chemotaxis
|
GO:0010758 |
8 |
0.022
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.022
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.022
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.021
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.021
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.021
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.021
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.021
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.021
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.021
|
|
|
|
disruption by host of symbiont cells
|
GO:0051852 |
11 |
0.021
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.021
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.020
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.020
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.020
|
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.020
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.020
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.020
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.020
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.020
|
|
|
|
multicellular organismal catabolic process
|
GO:0044243 |
7 |
0.020
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.020
|
|
|
|
modification of morphology or physiology of other organism involved in symbiotic interaction
|
GO:0051817 |
16 |
0.020
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.020
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.019
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.019
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.019
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.019
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.019
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.019
|
|
|
|
positive regulation of adiponectin secretion
|
GO:0070165 |
1 |
0.019
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.019
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.018
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
14 |
0.018
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.018
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.018
|
|
|
|
positive regulation of eosinophil migration
|
GO:2000418 |
2 |
0.018
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.018
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.018
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.018
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.018
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.018
|
|
|
|
sclerotome development
|
GO:0061056 |
4 |
0.018
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.018
|
|
|
|
semaphorin plexin signaling pathway involved in outflow tract morphogenesis
|
GO:0071527 |
1 |
0.018
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.018
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.018
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.017
|
|
|
|
face development
|
GO:0060324 |
38 |
0.017
|
|
|
|
bone trabecula formation
|
GO:0060346 |
9 |
0.017
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.017
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.017
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
38 |
0.017
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.017
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.017
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.017
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.017
|
|
|
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.017
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.017
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.017
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.017
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.017
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.017
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.016
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.016
|
|
|
|
protein trimerization
|
GO:0070206 |
13 |
0.016
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.016
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.016
|
|
|
|
regulation of eosinophil migration
|
GO:2000416 |
2 |
0.016
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.016
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.016
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.016
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.016
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.016
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.016
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.016
|
|
|
|
negative regulation of tooth mineralization
|
GO:0070171 |
1 |
0.016
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.016
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.016
|
|
|
|
negative regulation of odontogenesis
|
GO:0042483 |
3 |
0.015
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.015
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.015
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.015
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.015
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.015
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.015
|
|
|
|
regulation of bone resorption
|
GO:0045124 |
24 |
0.015
|
|
|
|
bone trabecula morphogenesis
|
GO:0061430 |
12 |
0.015
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.015
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.015
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.015
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.015
|
|
|
|
complement activation lectin pathway
|
GO:0001867 |
5 |
0.015
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.015
|
|
|
|
response to bmp
|
GO:0071772 |
14 |
0.015
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.015
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.015
|
|
|
|
synaptic transmission cholinergic
|
GO:0007271 |
7 |
0.014
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.014
|
|
|
|
response to nitric oxide
|
GO:0071731 |
4 |
0.014
|
|
|
|
direct ossification
|
GO:0036072 |
5 |
0.014
|
|
|
|
physiological muscle hypertrophy
|
GO:0003298 |
3 |
0.014
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.014
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.014
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.014
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.014
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.014
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.014
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.014
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.014
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.014
|
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.014
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.014
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.014
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.014
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.014
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.014
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.014
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.014
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.014
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.014
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.014
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.014
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.014
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.014
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.013
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.013
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.013
|
|
|
|
regulation of angiotensin metabolic process
|
GO:0060177 |
4 |
0.013
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.013
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.013
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.013
|
|
|
|
response to catecholamine
|
GO:0071869 |
4 |
0.013
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.013
|
|
|
|
cartilage condensation
|
GO:0001502 |
18 |
0.013
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.013
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.013
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.013
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.013
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.013
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.013
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.013
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.013
|
|
|
|
regulation of interleukin 1 alpha production
|
GO:0032650 |
4 |
0.013
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.013
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
33 |
0.013
|
|
|
|
regulation of odontogenesis
|
GO:0042481 |
18 |
0.013
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.013
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.013
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.012
|
|
|
|
chondroitin sulfate metabolic process
|
GO:0030204 |
17 |
0.012
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.012
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.012
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.012
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.012
|
|
|
|
killing of cells in other organism involved in symbiotic interaction
|
GO:0051883 |
13 |
0.012
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.012
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.012
|
|
|
|
chondrocyte morphogenesis
|
GO:0090171 |
1 |
0.012
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.012
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.012
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.012
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.012
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.012
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.012
|
|
|
|
killing of cells of other organism
|
GO:0031640 |
13 |
0.012
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.012
|
|
|
|
polysaccharide biosynthetic process
|
GO:0000271 |
20 |
0.012
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.012
|
|
|
|
sequestering of bmp in extracellular matrix
|
GO:0035582 |
3 |
0.012
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.012
|
|
|
|
muscle hypertrophy
|
GO:0014896 |
24 |
0.012
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.012
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.012
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.012
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.012
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.011
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.011
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.011
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.011
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.011
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.011
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.011
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.011
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.011
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.011
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.011
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.011
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.011
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.011
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.011
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.011
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.011
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.011
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.011
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.011
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.011
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.011
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.011
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.011
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.011
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.011
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.011
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.011
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.011
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.011
|
|
|
|
neutrophil mediated killing of gram positive bacterium
|
GO:0070946 |
2 |
0.011
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.010
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.010
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.010
|
|
|
|
modulation of growth of symbiont involved in interaction with host
|
GO:0044144 |
19 |
0.010
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.010
|
|
|
|
aorta smooth muscle tissue morphogenesis
|
GO:0060414 |
2 |
0.010
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.010
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.010
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.010
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.010
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.010
|
|
|
|
ossification involved in bone maturation
|
GO:0043931 |
12 |
0.010
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.010
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.010
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.010
|
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.010
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.010
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.010
|
|